Literature DB >> 33576237

COVID-19: Are Non-Communicable Diseases Risk Factors for Its Severity?

Bashir Bello1, Ushotanefe Useh1.   

Abstract

OBJECTIVE: To identify and describe the mechanisms of lifestyle characteristics-obesity, DM, hypertension and physical inactivity-that may lead to the severity of illness among individuals with COVID-19. DATA SOURCE: A scoping review was conducted by searching electronic databases of PubMed and Scopus from December 2019 to August 2020. INCLUSION/EXCLUSION CRITERIA: inclusion criteria were studies that explicitly describe the mechanism of COVID-19 in relationship with either hypertension, type 2 diabetes mellitus type 2 (DM), obesity and/or physical inactivity. Studies of epidemiological background, descriptive surveys and interventional studies were excluded. DATA EXTRACTION: study characteristics were tabulated according to purpose, type of non-communicable diseases (NCDs), the hypothesis on the mechanism of infestation (MOI) and conclusion. DATA SYNTHESIS: NCDs were categorized according to type and hypothesis on mechanisms of infestation. The interplay between COVID-19, type of NCDs and MOI leading to the severity of the disease was appraised.
RESULTS: Twenty-four (24) studies were identified from 357 unique records. Eight studies postulated the mechanism of infestation and interaction between COVID 19 illness severity and Obesity, while 7 studies described COVID-19 and DM. Five studies highlighted the interaction between COVID-19 and hypertension with 4 studies showing how physical activity restriction suppresses immunity.
CONCLUSION: The current review, identified and explicitly described the mechanisms of the lifestyle characteristics that may increase the severity of illness among people with COVID-19.

Entities:  

Keywords:  COVID-19; diabetes mellitus; disease management; hypertension; illness severity; infectious diseases; lifestyle risk factors; non-communicable diseases; obesity; physical inactivity

Mesh:

Year:  2021        PMID: 33576237     DOI: 10.1177/0890117121990518

Source DB:  PubMed          Journal:  Am J Health Promot        ISSN: 0890-1171


  6 in total

1.  Assessment of the Health-Promoting Behaviors of Hospitalized Patients with Non-Communicable Diseases During the Second Wave of COVID-19.

Authors:  Vachira Posai; Wanich Suksatan; Bovornpot Choompunuch; Apinya Koontalay; Jatuporn Ounprasertsuk; Jonaid M Sadang
Journal:  J Multidiscip Healthc       Date:  2021-08-13

Review 2.  Reviving the mutual impact of SARS-COV-2 and obesity on patients: From morbidity to mortality.

Authors:  Tapan Behl; Sachin Kumar; Sukhbir Singh; Saurabh Bhatia; Ali Albarrati; Mohammed Albratty; Abdulkarim M Meraya; Asim Najmi; Simona Bungau
Journal:  Biomed Pharmacother       Date:  2022-05-24       Impact factor: 7.419

3.  Prevalence and risk characteristics of COVID-19 in outpatients: A cross-sectional study of New York-area clinics.

Authors:  Chanapong Rojanaworarit; Douglas Charles Lambert; Joseph Conigliaro; Eun Ji Kim
Journal:  J Med Life       Date:  2021 Sep-Oct

4.  Self-Care Practices of Patients with Non-Communicable Diseases during the COVID-19 Pandemic: A Qualitative Study.

Authors:  Apichai Wattanapisit; Tida Sottiyotin; Jaruporn Thongruch; Sanhapan Wattanapisit; Siranee Yongpraderm; Pichawee Kowaseattapon
Journal:  Int J Environ Res Public Health       Date:  2022-08-07       Impact factor: 4.614

5.  Impaired Glucose-Insulin Metabolism in Multisystem Inflammatory Syndrome Related to SARS-CoV-2 in Children.

Authors:  Valeria Calcaterra; Pietro Bosoni; Dario Dilillo; Savina Mannarino; Laura Fiori; Valentina Fabiano; Patrizia Carlucci; Elisabetta Di Profio; Elvira Verduci; Chiara Mameli; Gloria Pelizzo; Elena Zoia; Lucia Sacchi; Cristiana Larizza; Gianvincenzo Zuccotti
Journal:  Children (Basel)       Date:  2021-05-13

Review 6.  Nurse-Coordinated Blood Pressure Telemonitoring for Urban Hypertensive Patients: A Systematic Review and Meta-Analysis.

Authors:  Woo-Seok Choi; Nam-Suk Kim; Ah-Young Kim; Hyung-Soo Woo
Journal:  Int J Environ Res Public Health       Date:  2021-06-27       Impact factor: 3.390

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.